SBS - Companhia de Saneamento Básico do Estado de São Paulo - SABESP
| Previous close | 15.12 |
| Open | 14.81 |
| Bid | 14.66 x 1200 |
| Ask | 14.67 x 1200 |
| Day's range | 14.52 - 14.83 |
| 52-week range | 9.26 - 15.40 |
| Volume | 590,391 |
| Avg. volume | 1,445,708 |
| Market cap | 9.995B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 19.69 |
| EPS (TTM) | 0.75 |
| Earnings date | N/A |
| Forward dividend & yield | 0.30 (2.01%) |
| Ex-dividend date | 29 Apr 2019 |
| 1y target est | 16.77 |
- Zacks
American Water to Invest $20-$22B to Fortify Infrastructure
American Water Works (AWK) announces a 10-year capital investment plan. The planned $20-$22B spending is set to strengthen its existing infrastructure.
- Zacks
SABESP's (SBS) Q3 Earnings and Revenues Surpass Estimates
SABESP's (SBS) Q3 earnings and revenues are better than expected due to higher billed water and sewage volumes.
- Zacks
New Strong Sell Stocks for August 22nd
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
- Zacks
SABESP's (SBS) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
Despite an earnings miss in the second quarter, SABESP (SBS) registers a 2.6% year-over-year improvement in billed water and sewage volumes.
- Zacks
American States Water Receives Electric Rate Case Approval
CPUC forwards approval to American States Water's (AWR) BVES unit to construct capital projects of nearly $44 million over a 5-year period.
- Zacks
American Water Works Receives Rate Case Approval in Kentucky
American Water Works (AWK) to make $100-million investment toward infrastructure, following the receipt of approved water rates.
- Zacks
Sabesp (SBS) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sabesp (SBS) have what it takes? Let's find out.
- Zacks
American Water (AWK) Arm to Invest $0.65M in Water Treatment
American Water (AWK) has been making continued investment in strengthening its existing water & wastewater infrastructure, and plans to invest within $8-$8.6 billion in the 2019-2023 time frame.
- Zacks
American States Water (AWR) Gets General Rate Case Approval
CPUC's water general rate case approval will allow further infrastructure investments for American States Water (AWR).
- EQS Group
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC SE 03.06.2019 / 18:03 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. * * *Notification of Major Holdings 1\. Details of issuer Name: STRATEC SE Street: Gewerbestr. 37 Postal code: 75217 City: Birkenfeld Germany Legal Entity Identifier (LEI): 529900ZZJWANAFSPGV30 2\. Reason for notification Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason: Acquisition and Merger with Oppenheimer Funds Inc. : please see Section 10 3\. Details of person subject to the notification obligation Legal entity: Invesco Ltd. City of registered office, country: Hamilton, Bermuda 4\. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. Invesco Oppenheimer International Small-Mid Company Fund 5\. Date on which threshold was crossed or reached: 24 May 2019 6\. Total positions % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 6.29 % 0.00 % 6.29 % 11969245 Previous notification n/a % n/a % n/a % / 7\. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000STRA555 0 753387 0.00 % 6.29 % Total 753387 6.29 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 % Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0.00 % Total 0 0.00 % 8\. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Invesco Ltd. % % % Invesco Holding Company Limited % % % Invesco Holding Company(US), Inc. % % % Invesco Group Services, Inc. % % % Invesco Advisers, Inc. 6.29 % % 6.29 % 9\. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: Proportion of voting rights Proportion of instruments Total of both % % % 10\. Other explanatory remarks: Acquisition and Merger with Oppenheimer Funds Inc. Please see following link for further information: https://ir.invesco.com/investor-relations/press-releases/default.aspx?_ga=2.153008441.1018859822.1558359393-832691936.1556037780 Date 29 May 2019 * * *03.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: STRATEC SE Gewerbestr. 37 75217 Birkenfeld Germany Internet: www.stratec.com End of News DGAP News Service
- EQS Group
STRATEC ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND ELECTS NEW SUPERVISORY BOARD
DGAP-News: STRATEC SE / Key word(s): AGM/EGM 29.05.2019 / 16:16 The issuer is solely responsible for the content of this announcement. * * *STRATEC ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND ELECTS NEW SUPERVISORY BOARDBirkenfeld, May 29, 2019At the Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard) held today in Pforzheim, the company's shareholders approved all agenda items submitted for resolution with clear majorities. Around 85.50% of the company's share capital was represented at the meeting.STRATEC will be distributing a dividend of EUR 0.82 per share to its shareholders for the past 2018 financial year (previous year: EUR 0.80). Shareholders will therefore receive a higher dividend for the fifteenth consecutive year. The dividend will be paid out to shareholders via their depositing banks on June 4, 2019.Shareholders also approved the actions of the Board of Management and the Supervisory Board and endorsed the appointment of Ebner Stolz GmbH & Co. KG Wirtschaftsprüfungsgesellschaft, Stuttgart, as auditor and group auditor for the 2019 financial year.Furthermore, shareholders approved the proposals submitted by the Supervisory Board in respect of its reelection. Dr. Frank Hiller was newly elected to the three-member Supervisory Board and has replaced the departing Supervisory Board Chairman Fred K. Brückner. After 21 years on the company's Supervisory Board, 19 of which as Chairman, Fred K. Brückner no longer stood for election and is now retiring. Rainer Baule and Prof. Dr. Stefanie Remmele stood for election once again and were reelected to the Supervisory Board. At its constitutive meeting held directly after the Annual General Meeting, the new Supervisory Board of STRATEC SE elected Dr. Frank Hiller as its Chairman and Rainer Baule once again as Deputy Chairman. Rainer Baule will also assume the role of financial expert.On behalf of the Board of Management, Supervisory Board, and Works Council, the Chairman of the Board of Management, Marcus Wolfinger, thanked Fred K. Brückner warmly for the excellent, trusting, and constructive working relationship over the past 21 years. Fred K. Brückner had been a member of STRATEC's Supervisory Board since the company was converted into a stock corporation in 1998. Since then, he had played a key role in all developments and major decisions at the company and had accompanied these with his expertise.Further information about the Annual General Meeting can be found at www.stratec.com/agm, where details of voting results will also be published.ABOUT STRATEC STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance.The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies.Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange.FURTHER INFORMATION IS AVAILABLE FROM: STRATEC SE Jan Keppeler, Investor Relations & Corporate Communications Gewerbestr. 37, 75217 Birkenfeld Germany Tel: +49 7082 7916-6515 Fax: +49 7082 7916-9190 ir@stratec.com www.stratec.com * * *29.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: STRATEC SE Gewerbestr. 37 75217 Birkenfeld Germany Phone: +49 (0)7082 7916 0 Fax: +49 (0)7082 7916 999 E-mail: info@stratec.com Internet: www.stratec.com ISIN: DE000STRA555 WKN: STRA55 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 816887 End of News DGAP News Service
- EQS Group
STRATEC REPORTS GOOD START TO THE 2019 FINANCIAL YEAR
DGAP-News: STRATEC SE / Key word(s): Quarter Results/Quarterly / Interim Statement 24.05.2019 / 07:00 The issuer is solely responsible for the content of this announcement. * * *STRATEC REPORTS GOOD START TO THE 2019 FINANCIAL YEAR\- Consolidated sales in Q1/2019 up 17.6% year-on-year at constant currency to EUR 47.7 million; nominal growth of 20.3% (Q1/2018: EUR 39.6 million) \- Adjusted EBIT for Q1/2019 +26.2% to EUR 5.1 million (Q1/2018: EUR 4.0 million) \- Adjusted EBIT margin improves year-on-year by 60 basis points to 10.7% \- Above-average number of product launches expected \- Ongoing high volume of development activities and rising employee totals \- Financial guidance for 2019 financial year confirmedBirkenfeld, May 24, 2019STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard) today announced its financial results and major events for the period from January 1, 2019 to March 31, 2019 with the publication of its Quarterly Statement Q1|2019.KEY FIGURES 1EUR 000s Q1/2019 Q1/20182 Change Sales 47,675 39,641 +20.3% Adjusted EBITDA 7,362 5,563 +32.3% Adjusted EBITDA margin (%) 15.4 14.0 +140 bps Adjusted EBIT 5,079 4,023 +26.2% Adjusted EBIT margin (%) 10.7 10.1 +60 bps Adjusted consolidated net income3 3,836 3,357 +14.3% Adjusted earnings per share (EUR)3 0.32 0.28 +14.3% Earnings per share (EUR)3 0.12 0.09 +33.3% bps = Basis points1 For comparison purposes, adjusted figures exclude amortization resulting from purchase price allocations in the context of acquisitions and the associated reorganization expenses, as well as other non-recurring effects. 2 Retrospectively restated for IFRS 9 and IFRS 15 and for classification of nucleic acid purification business as discontinued operation pursuant to IFRS 5. Not retrospectively restated for IFRS 16. 3 Results from continuing operations. BUSINESS PERFORMANCE Consolidated sales grew year-on-year by 20.3% to EUR 47.7 million in the first quarter of 2019 (Q1/2018: EUR 39.6 million). On a constant currency basis, this corresponds to growth of 17.6%. This sales growth was driven in particular by higher call-up numbers for systems in the Instrumentation segment. Thanks to recent product launches, sales in the Diatron segment also rose significantly compared with the previous year.Adjusted EBIT increased by 26.2% to EUR 5.1 million in the first quarter of 2019, compared with EUR 4.0 million in the previous year. As a result, the adjusted EBIT margin rose year-on-year by 60 basis points to 10.7%. The margin was positively affected in particular by the higher sales volumes and associated benefits of scale. This effect was nevertheless partly offset by increased costs in connection with the full development pipeline, higher personnel expenses relating to stock appreciation rights, and the product mix. In line with expectations, the launch of a new ERP system in January and the therefore scheduled interruption to production activities also impacted negatively on the company's performance.Due to the increase in operating profitability, adjusted consolidated net income from continuing operations also improved, in this case by 14.3% from EUR 3.4 million in the previous year to EUR 3.8 million. Adjusted earnings per share from continuing operations (basic) amounted to EUR 0.32, as against EUR 0.28 in the previous year's quarter.To facilitate comparison, the adjusted figures are stated net of the amortization of purchase price allocations resulting from acquisitions, associated restructuring expenses, and other non-recurring items. A reconciliation of the adjusted figures with the figures reported in the consolidated income statement has been provided in the Quarterly Statement Q1|2019 also published today.PROJECTS AND OTHER DEVELOPMENTS Due in particular to the high volume of development activities performed in recent years, STRATEC expects an above-average number of product launches in the 2019 financial year. Consistent with this expectation, in the first quarter of 2019 a North American partner already reported CE-IVD certification for a system designed and manufactured by STRATEC. The market launches of two further systems designed by STRATEC in cooperation with partners are also scheduled to take place by the middle of the year. Furthermore, proprietary developments in the platform and module businesses are planned to be launched onto the market in the second half of the year.On an operating level, the successful go-live of a new ERP system at the company's two largest production locations in Birkenfeld (DE) and Beringen (CH) in the first quarter of 2019 represented a major milestone. Following implementation at the Budapest (HU) and Anif (AT) locations in 2018 already, this means that all locations relevant to the STRATEC Group's production activities now have a uniform ERP system. Once the inefficiencies customary to the initial phase have been addressed, the new system will make cooperation between the locations significantly easier and enable processes to be structured more efficiently.DEVELOPMENT IN PERSONNEL Including personnel hired from a temporary employment agency and trainees, the STRATEC Group had a total of 1,217 employees as of March 31, 2019. This represents an increase of 9.6% compared with the previous year's reporting date. The ongoing growth in the number of employees is due in particular to the company's great need for highly qualified development employees in connection with its constantly growing development pipeline. STRATEC expects to require large numbers of additional highly qualified staff to implement the projects in its development pipeline in the years ahead as well.FINANCIAL GUIDANCE Based on its performance in the first quarter, which was in line with expectations, and the current order forecasts received from its customers, STRATEC confirms the financial guidance issued for the 2019 financial year. STRATEC therefore still expects to generate sales growth adjusted for exchange rate effects of at least 12% in 2019 (basis: EUR 187.8 million) and an adjusted EBIT margin of around 14% to 15% (2018: 13.9%).Given the construction work underway to significantly expand capacities at its headquarters in Birkenfeld and investments in numerous development projects, STRATEC expects its investment ratio to remain at an above-average high level in 2019. The company has budgeted investments in property, plant and equipment and intangible assets corresponding to around 12% to 14% of sales for 2019 (previous year: 10.3%). However, the investment ratio will likely decline considerably from 2020 onwards once the construction measures have been completed.QUARTERLY STATEMENT Q1|2019 The Quarterly Statement Q1|2019 of STRATEC SE is published on the company's website at www.stratec.com/financial_reports.CONFERENCE CALL AND AUDIO WEBCAST To comment on the publication of the results of the first quarter 2019, we will be holding a conference call in English today, Friday, May 24, 2019, at 2.00 p.m. (CEST).You will receive the access data (telephone number, password + individual PIN) after brief registration via the following link: www.stratec.com/registrationThe conference call can also be followed as an audio webcast at www.stratec.com/audiowebcast20190524 (brief registration necessary). Please note that it is not possible to submit any questions via the audio webcast. You can also use this link to follow or download the slide presentation.ABOUT STRATEC STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance.The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies.Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange.FURTHER INFORMATION IS AVAILABLE FROM: STRATEC SE Jan Keppeler, Investor Relations & Corporate Communications Gewerbestr. 37, 75217 Birkenfeld Germany Tel: +49 7082 7916-6515 Fax: +49 7082 7916-9190 ir@stratec.com www.stratec.com * * *24.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: STRATEC SE Gewerbestr. 37 75217 Birkenfeld Germany Phone: +49 (0)7082 7916 0 Fax: +49 (0)7082 7916 999 E-mail: info@stratec.com Internet: www.stratec.com ISIN: DE000STRA555 WKN: STRA55 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 815435 End of News DGAP News Service
- Zacks
American Water's Arm Chalks Out Investment Plans for 2019
American Water Works' (AWK) unit, Pennsylvania American Water, will invest nearly $355 million in 2019, which will enable it to provide quality services to the expanding customer base.
- Zacks
SABESP's (SBS) Q1 Earnings Miss Estimates, Revenues Beat
SABESP (SBS) surpasses first-quarter revenue expectation, and increases water and sewage billed volumes year over year in the reported quarter.
- Associated Press
Sabesp: 1Q Earnings Snapshot
On a per-share basis, the Sp, Brazil-based company said it had net income of 25 cents. The waste management company posted revenue of $1.03 billion in the period. Sabesp shares have climbed 50% since the ...
- Zacks
Here's Why Momentum Investors Will Love Sabesp (SBS)
Does Sabesp (SBS) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks
This is Why Sabesp (SBS) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sabesp (SBS) have what it takes? Let's find out.
- Zacks
American Water's Unit to Acquire East Pasadena Water Company
American Water Works' (AWK) unit California American Water enters into an agreement to acquire assets of East Pasadena Water Company and further expand operation in California.
- Zacks
SABESP's (SBS) Q4 Earnings & Revenues Surpass Estimates
SABESP's (SBS) fourth-quarter earnings and revenues surpass expectations, courtesy of improvement in total water and sewage billed volumes.
- Associated Press
Sabesp: 4Q Earnings Snapshot
On a per-share basis, the Sp, Brazil-based company said it had profit of 58 cents. The waste management company posted revenue of $1.29 billion in the period. For the year, the company reported profit ...
